More experimental details, TEM characterization of cit-Au, Au@Pt, and cit-Pt, EDS of Au@Pt, adsorption kinetics of DOPC mixed of cit-Pt, LipN DOPC, LipNM 20%Chol, LipNM 30%Chol, DLS data, MSD and De ...

Spoonful of spice in your milk could kill off cancer cells, experts say Various studies claim this warm, colourful ingredient is packed with remarkable health properties – and can be enjoyed as ...

A young mother-of-one is given just 12 months to live after being diagnosed with aggressive stomach cancer—linitis plastica, a rare type of adenocarcinoma that is incurable. Georgia Gardiner said her ...

In MTT assay, a yellow tetrazole of tetrazolium salt is converted to a purple formazan product by the NADPH-dependent oxidoreductase activity of active cells of the mitochondrial reaction center, ...

Despite her commitment to fitness, Bianca Harvey received a life-altering cancer diagnosis at age 34. Now Harvey's treatment has her cancer shrinking by over 50%, offering hope for remission.

Brazilian scientists find BamazScplp1 molecule in Amazon scorpion venom that targets breast cancer cells without harming normal cells, showing promise for treatments.

When exposed to CBDCA, the MCF-7 cell lines did not undergo apoptosis, characterized by Caspase-3 activation. Instead, they entered a state of cellular senescence, allowing the cells to adapt and ...

Results An initial test cohort of 30 prostate cancer-positive samples and 12 cancer-negative samples was used as basis for the development and optimization of an epigenetic multiplex assay based ...

We demonstrate that substitutionally inert octahedral metal complexes, such as the iridium (III) carbene complex (1a), provide a useful source of potent inhibitors for unexplored oncogenic protein ...

In early lab tests, a molecule from the venom demonstrated effects similar to those of paclitaxel, a widely used chemotherapy drug. The compound attacked breast cancer cells by triggering necrosis, a ...

Moreover, PARPi-resistant tumor cells can be readily re-sensitized to PARPi by targeting Flt1 either genetically (Flt1 -suppression) or pharmacologically (axitinib). Importantly, a retrospective ...

Hepatocellular carcinoma cells impair T-cell activity by consuming lysine, which can be targeted with SLC3A2 inhibition or lysine supplementation as a therapeutic strategy to enhance antitumor ...